Skip to main content

What the FDA labels say about taking them together

Follitropin and follitropin alfa

Follitropin alfa's FDA label of September 2, 2025 names follitropin in its contraindications section; the follitropin labels PlainMeds reads (2) do not name follitropin alfa. The follitropin alfa label: “During or after use of GONAL-f, monitor for venous or arterial thromboembolic events Ovarian Torsion:”

Check it at the source: the follitropin FDA label on DailyMed (effective May 26, 2026); the follitropin alfa FDA label on DailyMed (effective September 2, 2025).

What does the follitropin label say about follitropin alfa?

Follitropin's label (effective May 26, 2026) and its 1 other brand-application label do not name follitropin alfa in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Follistim AQ), Organon LLC, effective May 26, 2026 (SPL set 48489027-e52b-4b10-ae74-4ba03839150c), via openFDA; the full label on DailyMed

What does the follitropin alfa label say about follitropin?

Follitropin alfa label, contraindications

CONTRAINDICATIONS GONAL-f is contraindicated in women and men who exhibit: Prior hypersensitivity to recombinant FSH products or one of their excipients.

Follitropin alfa label, warnings and precautions

During or after use of GONAL-f, monitor for venous or arterial thromboembolic events ( 5.3 ) Ovarian Torsion:

Source: FDA drug label (Gonal-f), EMD Serono, Inc., effective September 2, 2025 (SPL set ae85b9c3-e7eb-4981-a5d9-346050e8f189), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Follitropin generic labelers
0Follitropin alfa generic labelers
FollitropinFollitropin alfa
Labeled forn/an/a
Boxed warningNoNo
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?